Global burden of disease study: What are the benefits and challenges?

17 January 2013
Alexandra Hyde

On 5 February, Prof Charlotte Watts joins other global health experts on a panel to debate a key milestone in the study of global health.

The Global Burden of Disease Study (2010) is the largest ever effort to assess the global distribution and causes of diseases, injuries and health risk factors. It represents a landmark for the development of evidence-based global health policies. However, there have also been a number of conceptual and methodological criticisms of the study and questions remain on how it can be effectively applied.

The panel is convened by The Lancet and the European Centre on the Health of Societies in Transition (ECOHOST) on behalf of LSHTM. It forms part of Global Health Lab, a series of focussed discussions on key health challenges facing the international community today.  

Details as follows:

The Global Burden of Disease Study 2010: What are the benefits and challenges?

Tuesday 5 February 2013, 17.15 to 18.45 at the John Snow Lecture Theatre, London School of Hygiene & Tropical Medicine (find map and directions here).

Chaired by Martin McKee, ECOHOST, LSHTM  and Richard Horton, The Lancet                                                             

Speakers:

  • Sir Richard Peto, University of Oxford
  • Charlotte Watts, STRIVE, LSHTM
  • David Leon, LSHTM